| The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation R Maffei, J Bulgarelli, S Fiorcari, L Bertoncelli, S Martinelli, C Guarnotta, ... haematologica 98 (7), 1115, 2013 | 150 | 2013 |
| MYB controls erythroid versus megakaryocyte lineage fate decision through the miR-486-3p-mediated downregulation of MAF E Bianchi, J Bulgarelli, S Ruberti, S Rontauroli, G Sacchi, R Norfo, ... Cell Death & Differentiation 22 (12), 1906-1921, 2015 | 79 | 2015 |
| Physical contact with endothelial cells through β1-and β2-integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a … R Maffei, S Fiorcari, J Bulgarelli, S Martinelli, I Castelli, S Deaglio, ... haematologica 97 (6), 952, 2012 | 59 | 2012 |
| Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia S Fiorcari, S Martinelli, J Bulgarelli, V Audrito, P Zucchini, E Colaci, ... haematologica 100 (2), 253, 2015 | 56 | 2015 |
| Endothelin-1 Promotes Survival and Chemoresistance in Chronic Lymphocytic Leukemia B Cells through ETA Receptor R Maffei, J Bulgarelli, S Fiorcari, S Martinelli, I Castelli, V Valenti, D Rossi, ... PloS one 9 (6), e98818, 2014 | 55 | 2014 |
| Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone R Marasca, R Maffei, S Martinelli, S Fiorcari, J Bulgarelli, G Debbia, ... Hematological Oncology 31 (2), 88-95, 2013 | 51 | 2013 |
| Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial PA Ascierto, M Casula, J Bulgarelli, M Pisano, C Piccinini, L Piccin, ... Nature Communications 15 (1), 146, 2024 | 44 | 2024 |
| Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia R Maffei, S Fiorcari, J Bulgarelli, L Rizzotto, S Martinelli, GM Rigolin, ... Experimental hematology 42 (2), 126-136. e1, 2014 | 44 | 2014 |
| Dendritic cell vaccination in metastatic melanoma turns “non-T cell inflamed” into “T-cell inflamed” tumors J Bulgarelli, M Tazzari, AM Granato, L Ridolfi, S Maiocchi, F De Rosa, ... Frontiers in immunology 10, 2353, 2019 | 39 | 2019 |
| ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia S Martinelli, M Kanduri, R Maffei, S Fiorcari, J Bulgarelli, R Marasca, ... Epigenetics 8 (7), 720-729, 2013 | 38 | 2013 |
| Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience F de Rosa, L Ridolfi, L Fiammenghi, M Petrini, AM Granato, V Ancarani, ... Melanoma research 27 (4), 351-357, 2017 | 22 | 2017 |
| Radiotherapy and high-dose interleukin-2: clinical and immunological results of a proof of principle study in metastatic melanoma and renal cell carcinoma J Bulgarelli, C Piccinini, E Petracci, E Pancisi, AM Granato, F de Rosa, ... Frontiers in immunology 12, 778459, 2021 | 14 | 2021 |
| Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II … L Ridolfi, F de Rosa, L Fiammenghi, M Petrini, AM Granato, V Ancarani, ... BMJ open 8 (8), e021701, 2018 | 12 | 2018 |
| Effects of a diet based on foods from symbiotic agriculture on the gut microbiota of subjects at risk for metabolic syndrome S Turroni, E Petracci, V Edefonti, AM Giudetti, F D’Amico, L Paganelli, ... Nutrients 13 (6), 2081, 2021 | 10 | 2021 |
| Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide R Maffei, S Fiorcari, S Martinelli, S Benatti, J Bulgarelli, L Rizzotto, ... Leukemia & lymphoma 59 (2), 423-433, 2018 | 10 | 2018 |
| Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series L Gurrieri, L Mercatali, T Ibrahim, V Fausti, M Dall’Agata, N Riva, ... Journal of Neuro-Oncology 164 (1), 55-64, 2023 | 9 | 2023 |
| Stability program in dendritic cell vaccines: A “Real-world” experience in the immuno-gene therapy factory of romagna cancer center E Pancisi, AM Granato, E Scarpi, L Ridolfi, S Carloni, C Moretti, ... Vaccines 10 (7), 999, 2022 | 5 | 2022 |
| First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax) L Ridolfi, L Gurrieri, N Riva, J Bulgarelli, F De Rosa, M Guidoboni, ... Frontiers in immunology 15, 1404861, 2024 | 4 | 2024 |
| Skewing effect of sulprostone on dendritic cell maturation compared with dinoprostone J Bulgarelli, L Fiammenghi, S Cassan, AM Granato, M Petrini, E Pancisi, ... Cytotherapy 20 (6), 851-860, 2018 | 4 | 2018 |
| Sequencing of checkpoint or BRAF/MEK inhibitors on brain metastases in melanoma PA Ascierto, M Mandalà, PF Ferrucci, M Guidoboni, P Rutkowski, ... NEJM evidence 3 (10), EVIDoa2400087, 2024 | 3 | 2024 |
Marasca RobertoUniversity of ModenaBestätigte E-Mail-Adresse bei unimore.it